Skip to content
Dra. María Natalia Gandur Quiroga· @nataliagandur · X·· 2 days agoScore70

NATALEE

Body · original

🚨 #ESMO26 moves fast your inbox should help you keep up, not add more noise.
@OncoAlert
The daily @OncoAlert Newsletter is LIVE from Madrid 🇪🇸 and delivers the most relevant congress data straight to your inbox every morning.

📌 Day 1 highlights
🎗️ NATALEE 6-year OS
🧬 PANKU-Breast01 + Lancet publication
🟠 KEYNOTE-866 & ENERGIZE two important negative MIBC trials
🟣 HERIZON-GEA-01 3-year OS

🎯 Why this matters: congress coverage is not about reading everything. It is about identifying the data that deserve attention, understanding what they mean, and moving quickly from headline to clinical context.

That is what @OncoAlert does best:

Less noise. More signal. Science that matters.

🤝 For colleagues, by colleagues.

📩 Register FREE: http://buff.ly/N5gYtAc
👉 Subscribe: http://OncoAlert360.com

@DrChoueiri @PGrivasMDPhD @AndreaNecchi @TiansterZhang @hoperugo @stolaney1 @christine_lovly @CathyEngMD @BenWestphalen @nataliagandur

#OncoAlert #ESMO26 #Oncology #CancerResearch #MedicalEducation

196 views · 3 likes · 1 repost · 0 replies

Conference abstracts
LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage

Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes

https://esmocongress.esmo.org
引用@
🚨 The daily OncoAlert Newsletter is LIVE from Madrid 🇪🇸 #ESMO26 REGISTER for Free 👉 https://buff.ly/N5gYtAc DELIVER STRAIGHT TO YOUR INBOX EVERY MORNING Day One #ESMO26 is in: 📌 NATALEE 6-yr OS 📌 PANKU-Breast01 + Lancet pub 📌 KEYNOTE-866 & ENERGIZE, both negative in MIBC 📌 HERIZON-GEA-01 3-yr OS For colleagues… by colleagues 🤝 Subscribe 👉 http://OncoAlert360.com @cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3
在 X 查看被引用的帖子

Source: Dra. María Natalia Gandur Quiroga · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org